The CDC has now published the Core Elements of Outpatient Antibiotic Stewardship in the Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, to provide guidance for antibiotic stewardship in outpatient settings.
Improving antibiotic use is critical to combating antibiotic-resistant bacteria,1 an important global public health problem. The CDC estimates that at least 30% of outpatient antibiotic prescriptions in the United States are completely unnecessary,2 illustrating why antibiotic stewardship is needed in outpatient settings. Antibiotic stewardship refers to the efforts aimed at improving and measuring antibiotic prescribing so that antibiotics are only used when needed; thus ensuring that the right drug, dose, and duration are selected, and minimizing misdiagnoses or delayed diagnoses, leading to underuse of antibiotics where they are needed.3,4 The CDC has now published the Core Elements of Outpatient Antibiotic Stewardship in the Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, on November 11, to provide guidance for antibiotic stewardship in outpatient settings. These Core Elements apply to clinics and clinicians in primary care, medical specialties and subspecialties, emergency departments, retail health and urgent care settings, and dentistry.
There are 4 Core Elements:
The Core Elements provide a framework for improving prescribing. It may be helpful to use the Core Elements with other quality improvement initiatives. For every unique outpatient facility, it is important to identify high-priority conditions that represent opportunities for improvement, to identify barriers to improving antibiotic use, and to establish clear evidence-based standards for antibiotic prescribing.
To view the Core Elements and learn more about antibiotic stewardship, please visit:
http://www.cdc.gov/getsmart/community/improving-prescribing/core-elements/core-outpatient-stewardship.html
References:
1. Seppälä H, Klaukka T, Vuopio-Varkila J, et al; Finnish Study Group for Antimicrobial Resistance. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 1997;337:441446. http://dx.doi.org/10.1056/NEJM199708143370701.
2. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among U.S. ambulatory care visits, 2010-2011. JAMA. 2016;315:18641873. http://dx.doi.org/10.1001/jama.2016.4151
3. CDC. Antibiotic resistance threats in the United States, 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. http://www.cdc.gov/drugresistance/threat-report-2013/index.html.
4. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51—77 http://dx.doi.org/10.1093/cid/ciw217.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More